JRC Publications Repository

JRC Publications Repository > Joint Research Centre > Institute for Transuranium Elements >

Please use this identifier to cite or link to this item: http://publications.jrc.ec.europa.eu/repository/handle/111111111/25496

Title: Therapeutic efficacy and toxicity of 225Ac-labelled vs. 213Bi-labelled tumour-homing peptides in a preclinical mouse model of peritoneal carcinomatosis
Authors: ESSLER M.
GAERTNER F. C.
NEFF Frauke
BLECHERT B.
SENEKOWITSCH-SCHMIDTKE R.
BRUCHERTSEIFER Frank
MORGENSTERN Alfred
SEIDL C.
Citation: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING vol. 39 no. 4 p. 602-612
Publisher: SPRINGER
Publication Year: 2012
JRC Publication N°: JRC68042
ISSN: 1619-7070
URI: http://www.springerlink.com/content/321l261540033028/
http://publications.jrc.ec.europa.eu/repository/handle/111111111/25496
DOI: 10.1007/s00259-011-2023-6
Type: Articles in Journals
Appears in Collections:Institute for Transuranium Elements

Files in This Item:

There are no files associated with this item.

Items in repository are protected by copyright, with all rights reserved, unless otherwise indicated.

 

The mission of the JRC is to provide customer-driven scientific and technical support for the conception, development, implementation and monitoring of EU policies. As a service of the European Commission, the JRC functions as a reference centre of science and technology for the Union. Close to the policy-making process, it serves the common interest of the Member States, while being independent of special interests, whether private or national.
Powered by DSpace
Top